Hutchmed China gets NMPA approval for ATLED in ICC
Hutchmed China Ltd received NMPA approval for ATLED (fanregratinib) for ICC.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.